References
- Jones T. R., Welsh K. M., Webber S., Davies J., Janson C. A., Matthews D. A., Smith W. W., Johnston A. L., Shetty B. V., Lewis K. K., Caldwell A. M., Romines W. H., Herrmann S. M., Galivan J., O'Connor B. M., Rhee M. S., Von Hoff D. D. “New lipophilic antifolates acting upon dihydrofolate reductase.”. Proc. Am. Assoc. Cancer Res. 1992; 33: 412
- Johnston A. L., Boritzki T. J., Huffaker T., Davidson J., Jones T. R., Webber S. “Biochemical properties and antitumor activity of three novel lipophilic antifolate compounds.”. Proc. Am. Assoc. Cancer Res. 1993; 34: 277
- Agalloco J., Akers J. “Current Practices in the Validation of Aseptic Processing.”. J. Parenteral Sci. Tech. 1993; 47: S1–S21
- Chiang C. C., Fessler D., Freebern K., Thirucote R., Tyle P. “Product Development of AG-331 Lyophilized Powder for Injection”. Journal of Pharmaceutical Science and Technology 1994; 48(1)24–29